| Literature DB >> 28448533 |
Chung Chang1, Meng-Ke Hsieh1, Wen-Yi Chang1, An Jen Chiang2,3, Jiabin Chen4,5.
Abstract
It is often helpful to classify biomarker values into groups of different risk levels to facilitate evaluation of a biological, physiological, or pathological state. Stratification of patients into two risk groups is commonly seen, but there is always need for more than two groups for fine assessment. So far, there are no standard methods or tools to help decide how many cutoff points are optimal. In this study, we developed a comprehensive package that included methods to determine both the optimal number and locations of cutoff points for both survival data and dichotomized outcome. We illustrated workflow of this package with data from 797 patients with cervical cancer. By analyzing several risk factors of cervical cancer such as tumor size, body mass index (BMI), number of lymph nodes involved and depth of stromal invasion, in relation to survival and clinical outcome such as lymph nodal metastasis and lymphovascular invasion, we demonstrated that the best choice for BMI and stromal invasion was two cutoff points and one for the others. This study provided a useful tool to facilitate medical decisions and the analyses on cervical cancer may also be of interest to gynecologists. The package can be freely downloaded.Entities:
Mesh:
Year: 2017 PMID: 28448533 PMCID: PMC5407800 DOI: 10.1371/journal.pone.0176231
Source DB: PubMed Journal: PLoS One ISSN: 1932-6203 Impact factor: 3.240
Fig 1Work flow of deciding the optimal number and locations of cutoff points.
Distribution of the patients’ baseline characteristics.
| Characteristics | Median (range) |
|---|---|
| Age, years | 54.6 (23–100) |
| BMI | 24.25 (12.67–48) |
| Tumor size, cm | 3.5 (0–17) |
| PFS | 3.39 (0.1–22.0) |
| OS | 3.57 (0.1–22.0) |
| FIGO | N (%) |
| IA1 | 39 (4.89) |
| IA2 | 10 (1.25) |
| IB | 20 (2.51) |
| IB1 | 281 (35.26) |
| IB2 | 134 (16.82) |
| IIA | 9 (1.13) |
| IIA1 | 37 (4.64) |
| IIA2 | 32 (4.01) |
| IIB | 96 (12.05) |
| IIIA | 15 (1.88) |
| IIIB | 45 (5.65) |
| IVA | 22 (2.76) |
| IVB | 27 (3.39) |
| unknown | 30 (3.76) |
| Histological type | N (%) |
| squamous cell carcinoma | 571 (71.64) |
| adenocarcinoma | 108 (13.55) |
| adenosquamous carcinoma | 16 (2.01) |
| small cell carcinoma | 5 (0.63) |
| Others | 14 (1.76) |
| unknown | 83 (10.41) |
| Relapse | 119 (14.93) |
| Death | 91 (11.42) |
* BMI: body mass index; PFS: progression free survival; OS: overall survival; FIGO: International Federation of Gynecology and Obstetrics.
# 4 undifferentiated, 2 clear cell carcinoma, 2 lymphoepithelioma, 1 endometrioid, 1 large cell neuroendocrine carcinoma, 1 leiomyosarcoma, 1 malignant melanoma, 1 sarcoma botryoides, and 1 stromal sarcoma
Optimal cutoff point: Total number of lymph node metastasis vs. survival.
| Training (n = 497) | Testing (n = 300) | |||||||
|---|---|---|---|---|---|---|---|---|
| Methods | Cutoff point | Recurrence | Death | |||||
| Recurrence | Death | NMLN | Stage | Histology | NMLN | |||
| Log-rank test | 5 | 5 | HR | 6.653 | 163.2 | 1 | 0.117 | 5.781 |
| 2 | 0.283 | |||||||
| Likelihood ratio test | 5 | 5 | p | 0.007 | 0.0004 | 1 | 0.004 | 0.035 |
| 2 | 0.281 | |||||||
* NMLN: number of metastatic lymph nodes, HR: hazard ratio. HR1 for histology was the hazard ratio of squamous cell carcinoma vs. other types, and HR2, adenocarcinoma vs. other types.
Optimal cutoff point of tumor size against risk of lymph node metastasis.
| Training (n = 497) | Testing (n = 300) | ||||
|---|---|---|---|---|---|
| Methods | Cutoff (cm) | Odds ratio | p value | AUC | Accuracy |
| Likelihood ratio test | 3.25 | 5.881 | <0.0001 | 0.700 | 0.674 |
| Maximum AUC | 3.25 | ||||
Fig 2BMI distribution against hazard ratio (HR) in the event of death.
Arrow marks position of the lowest HR. BMI histogram is illustrated with bars at the bottom of the figure.
Multiple cutoff points: Body mass index (BMI) vs. death.
| Training (n = 497) | Testing (n = 300) | |||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Methods | Cut 1 | Cut 2 | BMI | stage | Histological types | |||||||
| Log-rank test | 19.88 | 29.59 | HR1 | p 1 | HR2 | p 2 | HR | p | HR1 | p 1 | HR2 | p 2 |
| Likelihood test | 19.88 | 29.59 | 4.62 | 0.006 | 4.76 | 0.05 | 9.03 | 0.0002 | 0.175 | 0.002 | 0.161 | 0.043 |
*HR: hazard ratio. HR1 for BMI is the hazard ratio of low BMI over medium, and HR2, high over medium; HR1 for histological types is the hazard ratio of squamous cell carcinoma over other types, and HR2, adenocarcinoma over others.
Fig 3Kaplan-Meier curves for the three risk groups of BMI using the validation cohort of 300 patients.
The log-rank test showed significant difference in risk of death between the groups (p = 0.028).
Fig 4Nomogram of survival probabilities with independent risk factors using the validation cohort of 300 patients.
Survival probabilities after 1 year through 5 years are calculated based on the effects of the three risk factors.
Multiple cutoff points: Depth of stromal invasion (in fraction) against risk of lymphovascular space invasion (LVSI).
| Training (n = 497) | Testing (n = 300) | ||||||
|---|---|---|---|---|---|---|---|
| Method | Cut 1 | Cut 2 | OR | OR | p 1 | p 2 | AUC |
| Log-rank test | 0.32 | 0.97 | 5.085 | 39.38 | 0.037 | <0.0001 | 0.73 |
| Maximum AUC | 0.32 | 0.97 | |||||
* OR: odds ratio. The reference for calculating the odds ratios was set at the low risk group.
Comparison of Findcut and X2: Stromal invasion vs. LVSI.
| Methods | Training (n = 497) | Testing (n = 300) | ||
|---|---|---|---|---|
| Cutoff positions | sensitivity + specificity | AUC | Accuracy | |
| X2, 1 cutoff | 1 | 1.25 | 0.63 | 0.62 |
| X2, 2 cutoffs | 0.30, 0.88 | 1.33 | 0.68 | 0.66 |
| Findcut, 2 cutoffs | 0.32, 0.97 | 1.41 | 0.74 | 0.70 |